oral picomolar & reversible CDK7 inhibitor

Ph. I candidate in breast cancer comb. Therapy

from previous CDK7 inhibitor SY-1365

Journal of Medicinal Chemistry

Syros Pharmaceuticals Inc.

Chemical structure of molecule SY-5609 Syros Pharmaceuticals CDK7 kinase inhibitor

4. The Syros Pharmaceuticals CDK7 kinase inhibitor, SY-5609, is a picomolar, reversible, and highly selective molecule with slow off-rate kinetics.  It follows a prior covalent clinical candidate from Syros. The…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: